Pfizer Announces Voluntary Nationwide Recall of Lo/Ovral®-28
and Norgestrel/Ethinyl Estradiol Tablets Due to
Possibility of Inexact Tablet Counts or Out of Sequence Tablets

Contact:
Consumer:
1-877-509-3935

Media:
Grace Ann Arnold – Media
(845) 602-4768
Graceann.Arnold@Pfizer.com

FOR IMMEDIATE RELEASE – January 31, 2012 – NEW YORK, N.Y. – Pfizer Inc. announced today that it has voluntarily recalled 14 lots of Lo/Ovral®-28 (norgestrel and ethinyl estradiol)Tablets and 14 lots of Norgestrel and Ethinyl Estradiol Tablets (generic) for customers in the U.S. market. An investigation by Pfizer found that some blister packs may contain an inexact count of inert or active ingredient tablets and that the tablets may be out of sequence. The cause was identified and corrected immediately.

These products are oral contraceptives indicated for the prevention of pregnancy in women who elect to use oral contraceptives as a method of contraception. These tablets were manufactured and packaged by Pfizer Inc., commercialized by Akrimax Rx Products and labeled under the Akrimax Pharmaceuticals brand. This product is distributed to warehouses, clinics and retail pharmacies nationwide.

As a result of this packaging error, the daily regimen for these oral contraceptives may be incorrect and could leave women without adequate contraception, and at risk for unintended pregnancy. These packaging defects do not pose any immediate health risks. However, consumers exposed to affected packaging should begin using a non-hormonal form of contraception immediately. Patients who have the affected product (lot numbers are provided below) should notify their physician and return the product to the pharmacy.

These products are packaged in blister packs containing 21 tablets of active ingredients and seven tablets of inert ingredients. Correct dosing of this product is important in avoiding the associated risks of an unplanned pregnancy. Correctly packaged blister packs are pictured here.

Any adverse events that may be related to the use of these products should be reported to Akrimax Medical Information at 1-877-509-3935 (8 AM to 7 PM Mon-Fri CST) or to FDA’s Med Watch Program either online, by regular mail or by fax.

Online:              www.fda.gov/medwatch/report.htm
Regular Mail:   Use postage-paid, pre-addressed Form FDA 3500
available at: www.fda.gov/MedWatch/getforms.htm. Mail
to the address on the pre-addressed form.
Fax:                   1-800-FDA-0178

Pfizer has responded rapidly to ensure that its products continue to meet the company’s high quality standards. The safety of patients who take our medicines is our first priority.

This recall is being conducted with the knowledge of the U.S. Food and Drug Administration.

Lot numbers of affected packs of Lo/Ovral®-28 (norgestrel and ethinyl estradiol)Tablets and Norgestrel and Ethinyl Estradiol Tablets (generic) follow on the table below:

Related posts:

1. Caraco Digoxin Tablets Recalled
2. McNeil Consumer Healthcare Over-The-Counter Products: Recall
3. Teva Provides Update On Gemzar(R) Litigation
4. EPA, State of Colorado recognize Recovery Act benefits at Brighton Drinking Water facility (CO)
5. International Vitamin Corporation Recalls Live Better Vitamins Due to Failure to Meet Child-Resistant Closure Requirement

Related posts:

1. Mylotarg (gemtuzumab ozogamicin): Market Withdrawal
2. Vivitrol (naltrexone for extended-release injectable suspension): Medication Guide Required for Patients
3. Velcade (bortezomib): Starting Dose Adjustments for Patients with Hepatic Impairment
4. Velcade (bortezomib): Starting Dose Adjustments for Patients with Hepatic Impairment
5. Mesothelioma Patients’ Lives Extended Years In Study

Related posts:

1. Velcade (bortezomib): Starting Dose Adjustments for Patients with Hepatic Impairment
2. Velcade (bortezomib): Starting Dose Adjustments for Patients with Hepatic Impairment
3. CooperVision Avaira Toric Soft Contact Lenses: Class 1 Recall- Unintended Residue on Lenses
4. Delivering Cisplatin By Inhaler For Treating Lung Cancer
5. Delivering Cisplatin By Inhaler For Treating Lung Cancer

Related posts:

1. Magic Power Coffee: Undeclared Drug Ingredient
2. Atlas Operations, Inc.: Recall of Sexual Enhancement Products
3. MasXtreme Capsules (Natural Wellness) – product contains undeclared drug ingredient
4. FDA Takes Legal Action Against Dietary Supplement Maker In Pennsylvania
5. Birth Defects Caused by Dangerous Drugs are avoidable

Related posts:

1. Erythropoiesis-Stimulating Agents (ESAs): Procrit, Epogen and Aranesp: Drug Safety Communication
2. Sprycel (dasatinib): Drug Safety Communication – Risk of Pulmonary Arterial Hypertension
3. Mesothelioma Patients’ Lives Extended Years In Study
4. Cardiac Science Automated External Defibrillators – Powerheart, Cardiovive, NK, Responder models: Class I Recall
5. Stalevo (entacapone/carbidopa/levodopa): Ongoing Safety Review

Related posts:

1. GLAVAL ( 11V402000 )
2. GammaGard Liquid, Immune Globulin Intravenous (Human)
3. Benicar (olmesartan): Ongoing Safety Review
4. EPA to Increase Restrictions on Flea and Tick Products Cautions consumers to use products with extra care (HQ)
5. Stalevo (entacapone/carbidopa/levodopa): Ongoing Safety Review

Related posts:

1. Recall to Repair: Whitco Company LP Stadium Light Poles Can Fall Over, Posing Risk of Serious Injury and Death
2. Photon Climbing Carabiners and Quickdraws Recalled Due to Risk of Injury
3. Medical Malpractice Lawsuits
4. BD Q-Syte Luer Access Devices: Recall
5. BD Q-Syte Luer Access Devices: Recall

Related posts:

1. Stalevo (entacapone/carbidopa/levodopa): Ongoing Safety Review
2. GnRH Agonists: Safety Review of Drug Class Used to Treat Prostate Cancer
3. Avandia (rosiglitazone): Ongoing Review of Cardiovascular Safety
4. Oral Bisphosphonates: Ongoing Safety Review of Atypical Subtrochanteric Femur Fractures
5. Erythropoiesis-Stimulating Agents (ESAs): Procrit, Epogen and Aranesp: Drug Safety Communication

Related posts:

1. McNeil Consumer Healthcare Over-the-Counter Infants’ and Children’s Products: Recall
2. CPSC Educates New Parents on Safe Babywearing
3. MasXtreme Capsules (Natural Wellness) – product contains undeclared drug ingredient
4. Infant Deaths Prompt CPSC Warning About Sling Carriers for Babies
5. Atlas Operations, Inc.: Recall of Sexual Enhancement Products

Related posts:

1. Atlas Operations, Inc.: Recall of Sexual Enhancement Products
2. Cleviprex (clevidipine butyrate): Recall
3. Cardiac Science Automated External Defibrillators (Powerheart, Cardiovive, CardioLife, NK, Responder models): Class I Recall
4. Lo/Ovral-28 (Norgestrel/EthinylEstradiol) Tablets: Recall – Possibility of Inexact Tablet Counts or Out of Sequence Tablets
5. McNeil Consumer Healthcare Over-the-Counter Infants’ and Children’s Products: Recall

Related posts:

1. Virility Max: Recall – Undeclared Drug Ingredient
2. MasXtreme Capsules (Natural Wellness) – product contains undeclared drug ingredient
3. Atlas Operations, Inc.: Recall of Sexual Enhancement Products
4. FDA Takes Legal Action Against Dietary Supplement Maker In Pennsylvania
5. Miami Prescription Drug Diverter Sentenced To 70 Months In Prison

Related posts:

1. Xigris [drotrecogin alfa (activated)]: Market Withdrawal – Failure to Show Survival Benefit
2. Erythropoiesis-Stimulating Agents (ESAs): Procrit, Epogen and Aranesp: Drug Safety Communication
3. Senate Report Questions Avandia
4. Stalevo (entacapone/carbidopa/levodopa): Ongoing Safety Review
5. Arkansas woman files Reglan lawsuit

Related posts:

1. Teleflex Arrow IV Tubing Sets, Accessories, and Embolectomy Catheters: Recall
2. Judge says Vytorin Forum postings can stay
3. CPSC Issues Warning on Children’s Winter and Holiday-Themed Charm Bracelets with High Levels of Cadmium
4. Vitamin D Supplement Products: Medication Use Error
5. FTC, Florida Attorney General Charge Promoters of Bogus Alcohol Cure

Related posts:

1. Intravenous Medications Manufactured by Claris: Recall due to contamination of products
2. Hylenex recombinant (hyaluronidase human injection): Recall
3. Cleviprex (clevidipine butyrate): Recall
4. PediaCare Children’s Products [Blacksmith Brand]: Recall of four products
5. FTC Provides Comments to FCC on Protecting Children in Traditional and New Media Environments; FTC Approves Final Settlement Order Regarding The M Group, Inc., Doing Business As Bamboosa; FTC Approves Final Settlement Order Regarding Roaring Fork Valley Physicians I.P.A.; FTC Approves Final Settlement Order with Richard Stanton

Related posts:

1. Propylthiouracil
2. Arctic Cat Recalls Snowmobiles Due to a Loss of Control Hazard
3. Long-Acting Beta-Agonists (LABAs): New Safe Use Requirements
4. Obama To Release Revised Health Reform Proposal On Wednesday
5. ADA on Zinc in Denture Cream

Related posts:

1. Cleviprex (clevidipine butyrate): Recall
2. Hospira Brand Liposyn and Propofol: Recall
3. GammaGard Liquid, Immune Globulin Intravenous (Human)
4. McNeil Consumer Healthcare Over-The-Counter Products: Recall
5. Children’s Deaths Prompt Recall of Toy Dart Gun Sets Sold Exclusively at Family Dollar Stores

Related posts:

1. EPA Reminds Public: Avoid Contact with Contaminated Flood Water – Flood water can contain raw sewage, other harmful contaminants  (CT, ME, MA, NH, RI, VT)
2. U.S. EPA Takes Action Against South San Francisco Meat Processing Facility Following Hazardous Chemical Air Releases (CA)
3. CPSC Issues Warning on Children’s Winter and Holiday-Themed Charm Bracelets with High Levels of Cadmium
4. CPSC Chairman To Honor Consumer Product Safety Leaders
5. Benadryl Extra Strength Itch Stopping Gel: Packaging Changes to Reduce Use Errors

Related posts:

1. Hospira Brand Liposyn and Propofol: Recall
2. Metronidazole injection 500 mg / 100 ml: Voluntary recall due to non-sterility
3. Atlas Operations, Inc.: Recall of Sexual Enhancement Products
4. Vitamin D Supplement Products: Medication Use Error
5. Raynor Marketing Agrees to $390,000 Civil Penalty for Failing to Report Defective Office Chairs

Related posts:

1. Atlas Operations, Inc.: Recall of Sexual Enhancement Products
2. Cardiac Science Automated External Defibrillators – Powerheart, Cardiovive, NK, Responder models: Class I Recall
3. DEGS of Narrows LLC Settles Clean Air Act Violations (VA)
4. Jamestown, Rhode Island Wastewater Treatment Plant Recognized for Excellence (RI)
5. Essex Junction, Vermont Wastewater Treatment Plant Recognized for Excellence (VT)

Related posts:

1. Hylenex recombinant (hyaluronidase human injection): Recall
2. Cleviprex (clevidipine butyrate): Recall
3. WinRho SDF (Rho(D) Immune Globulin Intravenous (Human): Risk of Intravascular Hemolysis
4. Trilipix (fenofibric acid): Drug Safety Communication – Label Change
5. Baxter HomeChoice and HomeChoice PRO Automated Peritoneal Dialysis Systems: Class I Recall

Related posts:

1. Stalevo (entacapone/carbidopa/levodopa): Ongoing Safety Review
2. Benicar (olmesartan): Ongoing Safety Review
3. Senate Report Questions Avandia
4. Vivitrol (naltrexone for extended-release injectable suspension): Medication Guide Required for Patients
5. Zocor (simvastatin): increased risk of muscle injury with high doses

Related posts:

1. Napa Home & Garden Recalls NAPAfire and FIREGEL Pourable Gel Fuel Due to Fire and Burn Hazards
2. FTC Amends Free Credit Reports Rule To Help Consumers Steer Clear of ‘Free’ Offers that Cost Money
3. Zicam linked to Loss of Sense of Smell
4. Arrow Brand Medicated Oil and Embrocation: Consumer Warning, Product Considered Toxic
5. Scotch Corporation Recalls Instant Power Toilet Bowl Restorer

Related posts:

1. Intravenous Medications Manufactured by Claris: Recall due to contamination of products
2. Teleflex Arrow IV Tubing Sets, Accessories, and Embolectomy Catheters: Recall
3. Vivitrol (naltrexone for extended-release injectable suspension): Medication Guide Required for Patients
4. Covidien Initiates Voluntary Recall of Certain Shiley™ Tracheostomy Tubes
5. National, State Efforts Seek To Reduce Medical Errors

Related posts:

1. Velcade (bortezomib): Starting Dose Adjustments for Patients with Hepatic Impairment
2. Velcade (bortezomib): Starting Dose Adjustments for Patients with Hepatic Impairment
3. Xigris [drotrecogin alfa (activated)]: Market Withdrawal – Failure to Show Survival Benefit
4. Propylthiouracil
5. Arctic Cat Recalls Snowmobiles Due to a Loss of Control Hazard

Related posts:

1. Target Recalls Children’s Belts Due to Violation of Lead Paint Standard
2. Children’s Bracelets Recalled by Chandigarh Fashion Due to Violation of Lead Paint Standard
3. Sportime Recalls Sports Balls Due to Violation of Lead Paint Standard
4. Youth Tiara Recalled by Wilton Industries Due to Lead Exposure Hazard
5. Basketball-Shaped Chair and Ottoman Sets Recalled by Colleen Karis Designs Due to Violation of Lead Paint Standard; Sold at HomeGoods Stores

Related posts:

1. Benicar (olmesartan): Ongoing Safety Review
2. Stalevo (entacapone/carbidopa/levodopa): Ongoing Safety Review
3. Proton Pump Inhibitors (PPI): Class Labeling Change
4. Avandia (rosiglitazone): Ongoing Review of Cardiovascular Safety
5. Rare Diseases Pose Medico-legal Risk, From Medical And Dental Defence Union Of Scotland

Related posts:

1. Fashionviews Inc. Recalls P.Jamas Children’s Sleepwear Due to Violation of Federal Flammability Standard
2. Only New, Safer Cribs will be Available for Consumer Purchase on June 28, 2011
3. Pampers(r) Natural Stages Pacifiers Recalled by Key Baby Due to Choking Hazard
4. CPSC Lifts Stay of Enforcement on Flammability Requirements for Certain Non-Children’s Products
5. Rugby Children’s Pain & Fever Concentrated Drops Recalled Due To Failure to Meet Child-Resistant Closure Requirement

Related posts:

1. Virility Max: Recall – Undeclared Drug Ingredient
2. Cardiac Science Automated External Defibrillators (Powerheart, Cardiovive, CardioLife, NK, Responder models): Class I Recall
3. Cleviprex (clevidipine butyrate): Recall
4. McNeil Consumer Healthcare Over-The-Counter Products: Recall
5. Cardiac Science Automated External Defibrillators – Powerheart, Cardiovive, NK, Responder models: Class I Recall

Related posts:

1. Orlistat (marketed as Alli and Xenical): Labeling Change
2. Plavix (clopidogrel): Reduced effectiveness in patients who are poor metabolizers of the drug
3. ADA on Zinc in Denture Cream
4. Cleviprex (clevidipine butyrate): Recall
5. Benicar (olmesartan): Ongoing Safety Review

Related posts:

1. Benicar (olmesartan): Ongoing Safety Review
2. Avandia (rosiglitazone): Ongoing Review of Cardiovascular Safety
3. Genetic Link To Mesothelioma Discovered
4. Oral Bisphosphonates: Ongoing Safety Review of Atypical Subtrochanteric Femur Fractures
5. Erythropoiesis-Stimulating Agents (ESAs): Procrit, Epogen and Aranesp: Drug Safety Communication